؉ synthesizing enzyme Nmnat1, is reported to confer neuroprotection in vitro. However, an additional role for the N-terminal 70 amino acids (N70), derived from multiubiquitination factor Ube4b, has not been excluded. In wild-type Ube4b, N70 is part of a sequence essential for ubiquitination activity but its role is not understood. We report direct binding of N70 to valosin-containing protein (VCP; p97/Cdc48), a protein with diverse cellular roles including a pivotal role in the ubiquitin proteasome system. Interaction with Wld S targets VCP to discrete intranuclear foci where ubiquitin epitopes can also accumulate. Wld S lacking its N-terminal 16 amino acids (N16) neither binds nor redistributes VCP, but continues to accumulate in intranuclear foci, targeting its intrinsic NAD ؉ synthesis activity to these same foci. Wild-type Ube4b also requires N16 to bind VCP, despite a more C-terminal binding site in invertebrate orthologues. We conclude that N-terminal sequences of Wld S protein influence the intranuclear location of both ubiquitin proteasome and NAD ؉ synthesis machinery and that an evolutionary recent sequence mediates binding of mammalian Ube4b to VCP.
INTRODUCTION
The E4 ubiquitination factor Ube4b (or Ufd2a) has a 123-amino acid N-terminal region that is essential for ubiquitination activity (Mahoney et al., 2002) . It is unclear why this region is essential because it does not contain the U box, and it appears to be absent in invertebrate orthologues that ubiquitinate effectively (Koegl et al., 1999; Hatakeyama et al., 2001; Mahoney et al., 2002; Hoppe et al., 2004; Richly et al., 2005) . It is important to understand the molecular mechanism of Ube4b because it has a key role in the ubiquitin proteasome system (UPS; Hoppe, 2005) , it is neuroprotective in polyglutamine disorders and an important candidate gene for neuroblastoma (Krona et al., 2003) . Information on the substrates of Ube4b is beginning to emerge (Hoppe et al., 2004; Okumura et al., 2004; Spinette et al., 2004; Richly et al., 2005) but there is much still to learn about its regulation.
In the slow Wallerian degeneration mutant mouse (Wld S ), 70 amino acids of this essential domain of Ube4b form the N-terminus of a chimeric protein that delays Wallerian degeneration of injured axons in mice and rats by 10-fold (see Figure 1A ; Lunn et al., 1989; Mack et al., 2001; Adalbert et al., 2005) . The chimeric protein is absent in wild-type mice. This sequence (N70) is fused in Wld S protein to the full coding sequence of nicotinamide mononucleotide adenylyltransferase (Nmnat1; Conforti et al., 2000; Emanuelli et al., 2001; Mack et al., 2001 ), implicating the UPS or NAD ϩ metabolism in regulating axon degeneration. Wld S also delays axon degeneration in a wide range of neurodegenerative disorders and acute retrograde axonal degeneration after spinal injury, indicating that axon degeneration mechanisms are more closely related than previously thought (Wang et al., 2002; Ferri et al., 2003; Samsam et al., 2003; Coleman, 2005; Kerschensteiner et al., 2005; Mi et al., 2005) . Surprisingly, Wld S in vivo has only been found in nuclei, suggesting that downstream axonal effector(s) mediate its remarkable effect on axon degeneration (Mack et al., 2001; Samsam et al., 2003; Sajadi et al., 2004) .
Nmnat1 activity was reported to preserve injured axons for 3 d in vitro (Araki et al., 2004; Wang et al., 2005) . However, axons in vivo are far longer, have a profoundly different environment, and are protected by full-length Wld S for up to 3 wk (Crawford et al., 1995; Adalbert et al., 2005) . A contribution of N70 to strengthening the neuroprotective phenotype in vivo is suggested by the fact that transgenic mice overexpressing Nmnat1 show a normal rate of Wallerian degeneration (Coleman and Perry, 2002; Conforti and Coleman, unpublished data) . N70 could contribute to neuroprotection by perturbing the UPS, which is important for regulating axon degeneration (Zhai et al., 2003; Macinnis and Campenot, 2005) . Alternatively, it could influence intranuclear targeting of Nmnat1, with its intrinsic NAD ϩ synthesis activity, as Wld S protein clusters to discrete intranuclear foci in skeletal muscle (Mack et al., 2001) and in many neuronal subtypes in vivo (Haley et al., unpublished results) . The inability of successive investigators to detect any increase in NAD ϩ level when Nmnat1 is manipulated (Mack et al., 2001; Anderson et al., 2002; Araki et al., 2004) suggests that NAD ϩ is synthesized at highly localized intranuclear sites or immediately is passed to downstream components within the same complex. Either way, intranuclear targeting should be important.
To understand better the function of N70 in both Wld S and Ube4b proteins, we sought N70 binding partners. We identified valosin containing protein (VCP) as a direct binding partner of N70 that becomes targeted to discrete intranuclear foci when Wld S protein is present. VCP, one of the AAA family of ATPases associated with a variety of activities, has critical roles in the UPS (Dai and Li, 2001; Jarosch et al., 2002; Wang et al., 2004) and many other cellular roles dictated by interacting proteins (Meyer et al., 2000; Mogk et al., 2004; Wang et al., 2004) . It accumulates in neuronal nuclei in a range of neurodegenerative diseases and can influence neurodegeneration both positively and negatively (Hirabayashi et al., 2001; Higashiyama et al., 2002; Mizuno et al., 2003; Watts et al., 2004; Schroder et al., 2005) . Its intranuclear roles include interaction with Werner protein to influence the DNA damage response pathway (Indig et al., 2004) and the nuclear import of the T-cell-specific adaptor protein (Marti and King, 2005) . Our data suggest the possibility of further intranuclear roles for VCP and an important function for the N70 domain in both wild-type Ube4b and Wld S proteins.
MATERIALS AND METHODS

Constructs
VCP full-length cDNA was PCR-amplified with the Expand High Fidelity PCR System (Roche, Mannheim, Germany) from a mouse fibroblast cDNA library (kindly provided by R. Lange) using the 5Ј BamHI-and 3Ј SalI-tagged primers (restriction sites in bold): 5Ј-ATATATGGATCCCCATGGCCTCTG-GAGCCGATTC-3Ј; 5Ј-AATATTGTCGACTTAGCCATACAGGTCATCGTC-3Ј. The products were cloned with BamHI/SalI into pGEX5X-1 (Amersham Biosciences, Freiburg, Germany), and with NcoI/SalI into the pGBKT7 vector (BD Biosciences Clontech, Heidelberg, Germany). The Wld S protein, N70 and further truncation products were similarly PCR-amplified and cloned using the Wld S transgene construct (Mack et al., 2001 ) as template and appropriate primers based on the Wld S cDNA (GenBank AF260924). Human Ube4b was amplified from a construct kindly provided by Professor James Mahoney using primers 5Ј-ATCCCGGAATTCATGGAGGAGCTGAGCGCTGAT-3Ј and 5Ј-CCGCCTCGAGTTAGTGATCGCTGTTCTGTTT-3Ј (EcoRI and XhoI sites for cloning into pGEX5X-1 in bold). cDNA sequence encoding full-length Wld S protein, Nmnat-1 or Ube4b amino acids 1-70 (N70) was PCR-amplified from the Wld S transgene template (Mack et al., 2001 ) using the high-fidelity enzyme Pfu (Stratagene, Heidelberg, Germany) and appropriate combinations of the following primers (1 ϩ 2, 4 ϩ 2, and 1 ϩ 3, respectively). 5Ј restriction enzyme tags, added for cloning purposes, are shown in bold and the first or last three bases of sequence derived from the Wld S gene are underlined. A single base change to repress the stop codon of Wld S Rev and allow read-through of the C-terminal EGFP is double-underlined: 1) 5Ј-TAGATCCCAAGCTTAACCTTTCACCATTAAGAGGAAAGCGATG-3Ј; 2) 5Ј-GCGGGATCCCGTCCCAGAGTGGA-ATGGTTGTG-3Ј; 3) 5Ј-TCCTCCCCGCGGGTCTGCTGCACCTATGGGGGA-3Ј; and 4) 5Ј-GACTAGCTAGCATGGACTCATCCAAGAAGACAG-3Ј.
After cloning of pEGFP-N1 (BD Biosciences), all sequences were verified using the Taq FS BigDye-terminator cycle sequencing method on a ABI 377 prism sequencer and the corresponding ABI software. The sequences were analyzed using the GCG program Wisconsin Package Version 10.2 (Accelrys, San Diego, CA).
Full-length Wld S DsRed construct was generated by cloning the HindIII/ BamHI insert from pEGFP-N1 (above) into pDsRed2-N1 (BD Biosciences). Wld S lacking N16 was generated using the following HindIII and BamHItagged primers: 5Ј-TAGCCCAAGCTTTAGGCCGCCACCATGCTTGCTG-GTGGACAGACCT-3Ј; 5Ј-GCGGGATCCCGTCCCAGAGTGGAATGGTTG-3Ј.
Pulldown Assays
C57BL/6J mouse brain homogenates were used in this experiment to avoid competition from endogenous Wld S protein. Brains were flash-frozen and homogenized in 50 volumes of 50 mM Tris, pH 9.0, and 1% deoxycholate containing protease inhibitor mix (Sigma, Taufkirchen, Germany). After incubating for 30 min at 37°C, insoluble material was removed by centrifugation (10,000 ϫ g, 30 min) and the supernatant was dialyzed against binding buffer (50 mM Tris, pH 7.4, and 0.1% Triton X-100) overnight at 4°C. Homogenates were incubated overnight at 4°C with GST fusion proteins bound to glutathione Sepharose 4B. The beads were washed four times with phosphatebuffered saline (PBS)/0.1% Triton X-100 and resuspended in 3ϫ standard Laemmli sample buffer. Proteins were separated by SDS-PAGE on 12% gels and analyzed by Western blotting.
MALDI-TOF Mass Spectrometry
Proteins fished by a pulldown assay were eluted with double-concentrated SDS-PAGE sample buffer and separated by SDS-PAGE. From the gel individual Coomassie blue-stained protein bands were excised with a scalpel and destained by washing with 25 mM NH 4 HCO 3 /50% acetonitrile. For MALDI-TOF mass spectrometry analysis, the samples were dissolved in 5 l 0.1% aqueous trifluoroacetic acid. MALDI-MS was carried out in linear mode on a Bruker Reflex IV equipped with a video system (Rheinstetten, Germany), a nitrogen UV laser (Omax ϭ 337 nm), and a HiMass detector. One microliter of the sample solution was placed on the target and 1 l of a freshly prepared saturated solution of sinapinic acid in acetonitrile/H 2 O (2:1) with 0.1% trifluoroacetic acid was added. The spot was then recrystallized by addition of another 1 l acetonitrile/H 2 O (2:1), which resulted in a fine crystalline matrix. For recording of the spectra an acceleration voltage of 20 kV was used, and the detector voltage was adjusted to 1.9 kV. Approx. 500 single laser shots were summed into an accumulated spectrum. Calibration was carried out using the single and doubly protonated ion signal of bovine serum albumin for external calibration. Identification of the mass fingerprint spectra was performed using the Mascot program available from Matrix Science on the World Wide Web (http://www.matrixscience.com/home.html).
Isolation and Immunoprecipitation of Nuclear Proteins
Six mouse brains (ca. 2.5 g) were each homogenized using a Dounce homogenizer in 40 ml precooled nuclear isolation medium (NIM; 0.25 M sucrose, 25 mM KCl, 5 mM MgCl 2 , 10 mM Tris/HCl, pH 7.4) supplemented with protease inhibitor cocktail (Sigma). Unbroken cells and connective tissue were removed by filtration. The filtered homogenate was then diluted with an equal volume of ice-cold NIM, centrifuged (10 min, 800 ϫ g) and the pellet, including lipids, was resuspended in 40 ml NIM supplemented with protease inhibitor cocktail. After repeating the centrifugation, the new pellet was resuspended in 8 ml NIM, 2 ml sucrose density barrier (SDB; 2.3 M sucrose, 25 mM KCl, 5 mM MgCl 2 , 10 mM Tris/HCl, pH 7.4) solution was added and mixed thoroughly. 10 ml of the suspension was underlayered with 2.3 M sucrose and centrifuged for 1 h at 100,000 ϫ g in a Beckman SW41 Ti rotor (Krefeld, Germany). The pellet, together with remaining lipids, was resuspended in PBS containing 1% Triton X-100 and incubated for 2 h at 4°C with continuous agitation. Samples were then centrifuged at 16,000 ϫ g to generate a supernatant containing solubilized nuclear proteins.
For the subsequent immunoprecipitation, protein lysates were preincubated with 30 l of protein G agarose (Roche) for 2 h at 4°C under constant agitation. Samples were centrifuged (5 min, 500g) to remove proteins unspecifically bound to the protein G agarose and 3 l of anti-Wld S rabbit serum and another 30 l of protein G agarose were then added and incubated overnight at 4°C with constant agitation. The precipitated proteins bound to protein G agarose were then repeatedly washed by centrifugation at 500 ϫ g at 4°C for 5 min. The final pellet was resuspended in 1 ml PBS, 1% Triton X-100. Samples were then analyzed by SDS-PAGE and immunoblotting.
In Vitro Binding Assays
GST fusion proteins were purified and coupled to glutathione-Sepharose 4B according to the protocol of the manufacturer (Amersham Biosciences). The pGBKT7 constructs containing the T7 promoter were in vitro transcribed and translated incorporating 35 S-methionine using the TNT T7 Reticulocyte Lysate Coupled Transcription/Translation kit from Promega (Promega GmbH, Mannheim, Germany). The obtained proteins were mixed with equal amounts of GST fusion proteins and the binding assay was performed as previously described (Dai et al., 1998) . Reactions were analyzed by SDS-PAGE, and the gel was fixed with 10% methanol/10% acetic acid before autoradiography. Purified His-tagged VCP was a kind gift from Dr. Sarah Spinette (Johns Hopkins).
Cell Culture and Transfection
Plasmid DNA was isolated using the endonuclease free plasmid kit (QIAGEN, Hilden, Germany). DNA was transfected using LipofectAMINE 2000 (Invitrogen) into COS-7, PC12, or HeLa cells immediately before differentiation by culturing in 100 ng/l NGF on a type IV collagen substrate (Sigma). The "TV" PC12 subline, stably transfected with a tet-off inducible C-terminal EGFP-tagged VCP construct (Kobayashi et al., 2002) was grown in 1.0 g/ml doxycycline (Sigma), which was removed to induce VCP/EGFP expression. Protein location was observed 1-5 d after transfection. Spinal motor neurons from embryonic day 14 (E14) embryonic rats were cultured and electroporated in suspension as previously described (Henderson et al., 1995; Raoul et al., 2002) .
Immunocytochemistry
Slices of 100 m were cut from the cerebellum of Wld S mice and fixed in 4% paraformaldehyde (Fisher, Schwerte, Germany). Lumbar spinal cord dorsal root ganglia (DRG) were removed from Wld S mice or rats and fixed in 4% paraformaldehyde, and then 20-m sections cut on a cryostat. Slices were incubated for 2 h at room temperature in serum blocker consisting of 4% bovine serum albumin (Sigma) and 0.5% Triton X-100 (Sigma) in PBS. Wld-18 antibody (Samsam et al., 2003 ; 1:500 dilution) plus VCP antibody (against amino acids 9 -130; BD Biosciences; 1:200 dilution; or mouse monoclonal to VCP (ab11433); AbCam, Cambridge, United Kingdom, 1:500 dilution) were applied simultaneously in serum blocking solution overnight at 4°C. After washing with PBS, slices were incubated overnight at 4°C in a solution containing TRITC-conjugated anti-rabbit (DAKO, Hamburg, Germany; 1:20 dilution in PBS) plus Alexa488-conjugated anti-mouse (Molecular Probes, Leiden, Netherlands; 1:200) secondary antibodies. Slices were then washed in PBS and incubated in To-pro3 (Molecular Probes) for 10 min before mounting in Mowiol/DABCO preparation. Staining was visualized on a laser scanning confocal microscope (Bio-Rad Radiance 2000, Hemel Hempsted, United Kingdom) and Z-series were merged using Lasersharp (Bio-Rad) software.
Cultured cells were fixed for 30 min in 4% paraformaldehyde, permeabilized with Triton-X-100 (0.1%, 5 min), blocked with horse serum (5%, 1 h), and incubated with primary (1 h) and secondary (45 min) antibodies with multiple washes in PBS between each stage.
VCP antibody was used as described above. Anti-ubiquitin polyclonal antibody (DAKO) was used at 1:100 dilution and anti-neurofilament medium chain polyclonal antibody (Chemicon, Hofheim, Germany; Ab1987) was used as 1:1000. Images were taken on a Zeiss LSM 510 META confocal system (Oberkochen, Germany; LSM Software Release 3.2) coupled to a Zeiss Axiovert 200 microscope.
Western Blotting
Wld S protein expression was analyzed in mouse cerebella homogenized in five volumes of RIPA buffer, respectively, plus 1ϫ Complete protease inhibitor cocktail (Roche) or in PC12 cells scraped from the dish in a minimal volume of the same buffer. Proteins were separated by SDS-PAGE and semidry blotted onto nitrocellulose (Bio-Rad). Blocking and incubation with primary antibodies and horseradish peroxidase-conjugated secondary antibodies (1:5000; Serotec, Heidelberg, Germany) were performed in PBS plus 0.02% Tween-20 and 5% low fat milk. Proteins were visualized using the ECL detection kit (Amersham Biosciences) according to the manufacturer's instructions.
RESULTS
Wld
S Protein Binds Directly to VCP through its Nterminal Domain
A screen for Wld S binding partners revealed that a protein of ca. 97 kDa can be pulled down in large quantities from mouse brain homogenate by GST-Wld S ( Figure 1B ). N70 is sufficient for this activity. Isolation of this protein from an SDS-PAGE gel followed by MALDI-TOF mass spectrometry protein identification revealed several tryptic peptides exactly matching sequences from murine VCP ( Figure 1C ). To confirm that binding of Wld S to VCP is biologically relevant, we coimmunoprecipitated VCP specifically from nuclear extracts of Wld S mouse brain using antibody Wld-18 and confirmed the identity of VCP by Western blotting ( Figure 1D ). VCP could not be coimmunoprecipitated from wild-type mouse brain, which lacks Wld S protein. The reciprocal coimmunoprecipitation was inconclusive because VCP itself was not immunoprecipitated by the BD Biosciences anti-VCP antibody, but these data strongly suggest that the Wld S /VCP complex is biologically relevant. To determine whether the binding was direct or mediated by other factors, we precipitated purified His-tagged VCP (a kind gift from Dr. Sarah Spinette and Prof. Antony Rosen, Johns Hopkins) using GST-tagged N-terminal fragments of Wld S ( Figure 1E ; see also Figure 3 ). The ability of Wld S -derived peptides to precipitate VCP was retained in the absence of other relevant proteins, showing that VCP binds directly to the shared N-terminus of Wld S and Ube4b. Because Wld S protein has been suggested to alter the UPS (Zhai et al., 2003; Coleman and Ribchester, 2004) (Mack et al., 2001 ; Figure 2 ). After transient transfection of Wld S /EGFP fusion construct into PC12 cells, VCP partially shifted from the widespread nuclear and cytoplasmic distribution that was previously described (Hirabayashi et al., 2001; Kobayashi et al., 2002) and is present in untransfected cells ( Figure 2B , arrow) to produce the same pattern of intranuclear foci as Wld S ( Figure 2B , arrowhead). VCP is an abundant protein (Dai and Li, 2001) , so the wider nuclear and cytoplasmic pool remained without any obvious depletion (Figure 2 , A-C). VCP was also partially redistributed by Wld S in HeLa cells which, like PC12, remained healthy ( Supplementary Figures 2 and 4) .
To study this in vivo, we made use of the finding that cerebellar granule cells and molecular layer neurons also show intranuclear foci of Wld S protein, albeit of different size and number from PC12 cells (Haley et al., unpublished results) . Again Wld S and VCP colocalized within intranuclear foci in these neurons from Wld S mice (Figure 2 , D-F), whereas in wild-type cerebellum, there were no intranuclear VCP foci (Figure 2, G-I ). Some DRG neurons in both Wld S mice and rats also showed good colocalization (Supplementary Figure 5 ), indicating that the Wld S /VCP interaction occurs in at least some neurons known to express the neuroprotective Wld S phenotype and that this binding is conserved between species. The situation is less clear in motor neurons, where Wld S is more homogenously distributed in vivo (Mack et al., 2001; Samsam et al., 2003) , and VCP colocalization with Wld S spots was not evident in vitro (Supplementary Figure 5 ). Nevertheless, the data are sufficient to conclude that Wld S and VCP bind one another under phys-iological conditions, including in at least some neurons that display the Wld S phenotype.
VCP Binds within the First 16 Residues of Wld
S
We show above that Wld S binds to and partially redistributes VCP. To establish that binding causes redistribution, we mapped and then deleted key residues of Wld S required for VCP binding. Truncated N70 constructs were expressed as GST-fusion proteins and used to pull down IVTT-expressed VCP. First the N-terminal 23 amino acids were found to be necessary and sufficient for VCP binding, and this was subsequently narrowed to the N-terminal 16 amino acids (N16; Figure 3A ). Ube4b lacking this sequence also did not bind VCP. Two Wld S /DsRed2 constructs were then made: one full-length and one lacking N16, and transiently transfected into the TV PC12 stable subline that expresses VCP/EGFP fusion protein in a tet-off-inducible manner (a kind gift from Prof. Akira Kakizuka). Full-length Wld S /DsRed2 was able to bring about partial redistribution of VCP/EGFP into intranuclear foci in transfected cells (arrowhead; Figure 3 , B-E) but removal of N16 containing the VCP binding site prevented this (Figure 3, F-I) . Interestingly, the ability of Wld S protein to accumulate in intranuclear foci does not require binding to VCP ( Figure 3F ). Thus, VCP has to bind Wld S N16 to be partially redistributed in the manner we describe.
The Sequence Targeting Wld S Protein to Intranuclear Foci Is Not Nmnat1
Because VCP binding is not required to target Wld S to intranuclear foci, we asked whether this is a property of the Nmnat1 sequence by fusing Nmnat1 to EGFP and transiently transfecting it (Figure 4) . Nmnat1, but not N70, was restricted to the nucleus, confirming previous reports that Nmnat1 is a nuclear protein and suggesting that nuclear targeting of Wld S protein is due to the putative nuclear localization signal of Nmnat1 (Raffaelli et al., 2002; Araki et al., 2004; Magni et al., 2004) . However, unlike Wld S /EGFP, intranuclear distribution of Nmnat1/EGFP was homogeneous apart from its exclusion from nucleoli. The fraction of N70/EGFP that entered the nucleus was also homogeneously distributed, suggesting that Wld S protein is targeted to intranuclear foci either by a conformational structure involving both N70 and Nmnat1 sequence or by the short unique sequence that separates these two parts of the protein. Cell and nuclear shape indicated that the cells were healthy in all cases. We conclude that Nmnat1 and Wld S protein differ in their intranuclear distribution, but as shown above, their differing abilities to bind VCP do not underlie this difference.
Wld
S Also Can Partially Relocalize Ubiquitin inside the Nucleus VCP binds long ubiquitin chains (Dai and Li, 2001 ) so one consequence of its partial redistribution by Wld S protein could be redistribution of bound polyubiquitinated proteins. This was supported by immunocytochemistry of PC12 cells transiently transfected with Wld S /EGFP fusion construct ( Figure 5 , A-H). As with VCP, the normal distribution of ubiquitin throughout the nucleus and cytoplasm of untransfected cells is joined by a punctate intranuclear pattern in transfected cells, where ubiquitin puncta colocalize with Wld S /EGFP. Cell and nuclear shape indicated that the cells were healthy (see also Supplementary Figure 3) . The association of ubiquitin epitopes with Wld S also depended on the N16 sequence, suggesting it is secondary to VCP binding to Wld S ( Figure 5 , I-P). An alternative explanation for the accumulation of ubiquitin epitopes at these sites could be ubiquitination of the Wld S /EGFP fusion protein, so we looked for these putative ubiquitinated species by Western blotting (Figure 6 ). Wld-18 antibody detected only a single band of the expected size, even on long-exposure ECLs after a generalized accumulation of ubiquitination products due to proteasome inhibition. The intensity of the Wld S band did increase after proteasome inhibition, suggesting that Wld S protein is degraded by the UPS but despite this, ubiquitinated Wld S did not reach detectable levels on the Western blots. Although we cannot rule out the possibility that ubiquitinated Wld S contributes to the ubiquitin speckles, the inability to detect this putative species on a Western blot and the probable dependence on VCP binding suggest that putative ubiquitination of Wld S is unlikely to be the sole explanation for the ubiquitin speckles. Thus, we propose that polyubiquitinated proteins may accumulate in the Wld S /VCP complex.
VCP Binding to N16 Is an Evolutionary "Recent" Development
An alignment of human Ube4b with known orthologues shows that an N-terminal extension containing the N16 sequence is present in mammals, birds, fish, and insects, but this entire region is absent in nematodes, slime molds, and yeasts (Figure 7) . Nevertheless, the VCP ortholog Cdc48 does bind Ufd2 in Saccharomyces cerevisiae (Koegl et al., 1999; Richly et al., 2005) and Caenorhabditis elegans (C. Kähler and T. Hoppe, personal communication) so the interaction in these species must have a different molecular basis. The Cdc48 binding site in S. cerevisiae has been mapped (Richly et al., 2005) and mammals do have a sequence homologous to it. However, this sequence appears to be insufficient for VCP binding in human, because N-terminally truncated Ube4b did not bind VCP ( Figure 3A) . Mammalian Ube4b was previously reported to bind VCP (Meyer et al., 2000; Kaneko et al., 2003) but the interacting sequence was not fully mapped. Our data show that VCP binds to N16, and this appears to be a recent event in evolutionary terms with distantly related higher eukaryotes employing a different mode of interaction.
DISCUSSION
We report direct binding between VCP and the N-terminal 16 amino acids of Wld S protein (N16) that drives partial redistribution of VCP in nuclei in vivo and in vitro when full-length Wld S is present. N16 is necessary and sufficient for VCP binding and is necessary for relocalization of VCP, but is not required to target Wld S to discrete intranuclear foci. Thus, sequences outside N16 cause Wld S to accumulate at these sites and VCP is redistributed through binding to N16. The N-terminal domain of Wld S also influences the intranuclear distribution of the covalently attached Nmnat1 sequence and hence the distribution of nuclear NAD ϩ synthesis machinery.
A recent report indicates that Nmnat1, but not N70, is sufficient to confer a Wld S -like phenotype on neurons in vitro (Araki et al., 2004) . However, the relative strengths of the neuroprotective phenotypes induced by Nmnat1 and Wld S were not tested and Nmnat1 was not shown to protect in vivo, where Wld S robustly protects longer axons for far greater time periods (Mack et al., 2001; Adalbert et al., 2005) . Our data show that N70 is not an inert addition to Nmnat1, but instead concentrates VCP, NAD ϩ synthesis activity and probably its associated ubiquitinated proteins into sub- 35 S-labeled, IVTT expressed VCP pulled down with these constructs; right bottom, corresponding Coomassie-stained gel. Constructs a, b, and c, containing the first 23 residues, were able to pull down VCP, but the more C-terminal constructs d and e were not. The region necessary and sufficient for binding was subsequently narrowed to amino acids 1-16 using constructs f and g. Ube4b also pulled down VCP but failed to bind when this sequence was removed. Note that very little soluble full-length GST-Ube4b could be recovered by this method. However, this was sufficient to pull down VCP (lane h), whereas a greater amount of truncated GST-Ube4b (lane i) was not. Figure 6) , is expressed throughout the cytoplasm and most of the nucleus as previously reported (Hirabayashi et al., 2001; Kobayashi et al., 2002) nuclear sites, functions that each have potential to influence the strength of the Wld S phenotype. Thus, Wld S joins a growing list of chimeric proteins whose biological activity amounts to more than the sum of their parts (Fujimoto et al., 1996; Campbell et al., 1997; Blume-Jensen and Hunter, 2001) .
Further studies are needed to test whether VCP binding is required for the neuroprotective Wld S phenotype, but this possibility was upheld in two important tests. First, Wld S and VCP show colocalization in at least some DRG neurons known to express the neuroprotective phenotype, as well as in cerebellum where the phenotype in vivo remains to be tested. Second, colocalization was conserved across species in DRG of Wld S rats . The more homogeneous intranuclear distribution of Wld S in motor neurons in vivo makes colocalization in this cell type more difficult to test (Mack et al., 2001; Samsam et al., 2003) . Cultured motor neurons electroporated with Wld S /EGFP show Wld S puncta without obvious colocalization of VCP but this does not exclude a role for VCP in the neuroprotective phenotype in vivo (Supplementary Figure 5) .
Colocalization studies cannot ultimately answer the question of whether VCP is required for the Wld S phenotype. Unfortunately, VCP knockout mice are not available to test the hypothesis and a more complex strategy may be needed. Given the essential role of VCP in endoplasmic reticulumassociated protein degradation (ERAD) and several reports of damaging effects of VCP RNAi, mutation, and deletion in other species or cell lines, it is unlikely that such knockout mice would be viable (Hirabayashi et al., 2001; Kobayashi et al., 2002; Wojcik et al., 2004; Yamanaka et al., 2004) . In contrast, Wld S alters VCP in a way that leaves all cells and organisms healthy, with no overt harmful effect in the orig- S /EGFP localizes primarily to discrete intranuclear foci (arrowhead), although some remains homogeneously distributed inside the nucleus (arrow). (B) Nmnat1/EGFP is homogeneously distributed, apart from exclusion from nucleoli. N70/EGFP (C) and EGFP (D) alone are homogeneously distributed throughout the cell but EGFP has a preference for the nucleus as previously described (Alonso et al., 2004) . Neither is targeted to intranuclear foci. Scale bar, 10 m. inal mutant (Lunn et al., 1989) , four lines of transgenic mice (Mack et al., 2001) , three of rats or in double homozygous mice or rats (unpublished observations). This is likely to reflect the confinement of alterations to the nucleus, leaving the essential role of VCP in ERAD unaffected.
Studies in yeast suggest VCP stimulates substrate binding but limits the subsequent growth of a polyubiquitin chain (Richly et al., 2005) . However, VCP is dispensable for Ube4b activity when concentrated preparations of protein are used in vitro (Hatakeyama et al., 2001; Mahoney et al., 2002) and in these circumstances removal of the N-terminal 123 amino acids of Ube4b blocks activity for unknown reasons (Mahoney et al., 2002) . Our data further highlight the importance of the N-terminus of Ube4b as a regulatory sequence. Many invertebrates lack this sequence but still bind the VCP ortholog Cdc48, so this molecular interaction appears to have changed during evolution.
VCP plays pivotal roles in ERAD, nuclear envelope reconstruction, cell cycle, postmitotic Golgi reassembly, and suppression of apoptosis (Kondo et al., 1997; Dai and Li, 2001; Hetzer et al., 2001; Rabinovich et al., 2002; Wang et al., 2004) . Its nuclear functions are equally diverse. First, a nuclear transport role is suggested by its association with adapter proteins Ufd1 and Np14, and by VCP-dependent transport of T-cell-specific adaptor protein into eukaryotic nuclei (Meyer et al., 2000; Marti and King, 2005) . Second, VCP controls nucleolar retention of Werner syndrome helicase and its release after DNA damage (Indig et al., 2004) . Interestingly, our data fit with the proposal of these authors that other nuclear binding partners regulate VCP distribution and control other pathways. Third, the nucleus has a quality control pathway (Gardner et al., 2005) likely to involve VCP. Interaction and colocalization with expanded polyglutamine and other intranuclear inclusions suggests VCP may be trying to clear misfolded nuclear proteins (Hirabayashi et al., 2001; Doss-Pepe et al., 2003; Mizuno et al., 2003) . Finally, VCP regulates the stability of the transcription factor SPT23 (Richly et al., 2005) , consistent with the tight regulation of transcription by the UPS (Muratani and Tansey, 2003) .
VCP is altered in several neurodegenerative disorders so its interaction with the neuroprotective Wld S protein is particularly interesting. VCP missense mutations cause inclusion body myopathy with Paget disease of bone and frontotemporal dementia, a disease characterized by ubiquitin-containing nuclear inclusions and white matter pathology (Watts et al., 2004; Schroder et al., 2005) . VCP is present in Lewy-like inclusions in amyotrophic lateral sclerosis, in nigral Lewy neurites in Parkinson's disease (Ishigaki et al., 2004) , and in ubiquitin-positive intraneuronal inclusions in motor neuron disease with dementia, ballooned neurons in Creutzfeldt-Jakob disease, and dystrophic neurites of senile plaque in Alzheimer's disease (Mizuno et al., 2003) . In polyglutamine disorders such as Huntington's disease and Machado-Joseph disease, specific binding to expanded polyglutamine targets VCP to intranuclear inclusions (Hiraba- The database accession numbers are also shown. Mammals, birds, fish, and insects have sequence showing significant homology to the VCP binding site in N16 at positions denoted by the asterisk (*). Nematodes, slime molds, and yeasts lack the entire N-terminal extension containing this sequence. The Cdc48 binding site of S. cerevisiae Ufd2p (Richly et al., 2005) , the U box (Hatakeyama et al., 2001) , and the sequence essential for in vitro ubiquitination activity (Mahoney et al., 2002) are also marked. Black boxes, regions of significant homology to human Ube4b; open boxes, regions not homologous to human Ube4b; bold, amino acids identical to human sequence; underlined, conservative substitutions.
H.. Laser et al. yashi et al., 2001) . This interaction appears to influence disease severity, as loss-of-function mutations in the Drosophila VCP ortholog, ter4, dominantly suppress neurodegeneration caused by expanded polyglutamine (Higashiyama et al., 2002) .
It is now important to determine whether Wld S protein, or N70 can interfere with the effect of VCP in any of these neurodegenerative disorders. Ectopic expression in Drosophila of mammalian Ube4b suppresses polyglutamine disease, and loss of function mutations in VCP have a similar effect (Higashiyama et al., 2002; Matsumoto et al., 2004) . It is also now clear that Wld S and expanded polyglutamine both bind VCP directly and partially relocalize it to intranuclear foci (Hirabayashi et al., 2001) . Taken together, these observations raise the intriguing possibility that N70 and VCP antagonize each other in some circumstances as a result of the binding interaction we describe.
In summary, we report direct interaction between VCP and the N-terminal 16 amino acids of both Wld S and Ube4b proteins. This interaction drives focal intranuclear clustering of VCP in Wld S neurons, probably together with associated multiubiquitinated proteins, and helps understand the function of an important, evolutionarily recent regulatory sequence in the Ube4b protein. It is now important to determine whether the redistribution of covalently attached Nmnat1 or of bound VCP influences the strength of the Wld S phenotype in vivo and to understand how the Nterminal binding of VCP to Ube4b influences this ubiquitin ligase.
